Atherosclerosis clinical trials
47 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
- A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease
- Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
- Determining the Benefits of Exercise on Cardiovascular Risk in PTSD
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
- Pelacarsen Roll-over Extension Program
- A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
- Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease
- Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
- PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
- The Prevent Coronary Artery Disease Trial
- Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?
- Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
- Text Education About Cardiovascular Health and HIV (TEACH-HIV)
- Detecting Peripheral Artery Disease With the Pulse
- Optimizing Non-statin Agents for ASCVD
- The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
- CLAiR Pivotal Study
- Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions
- Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma
- Machine Learning for Handheld Vascular Studies
- Causes and Natural History of Dyslipidemias
- Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
- Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
- Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study
- How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses
- A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients
- Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
- High Protein Diet and Atherosclerosis
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Pharmacogenomic Informed Statin Prescribing
- New Heart Imaging Techniques to Evaluate Possible Heart Disease
- Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
- Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD
- Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE
- Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)
- Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors
- Improving Lipid Optimization Quality and Treatment Options in ASCVD
- A Study of DII235 in Adults With Elevated Lipoprotein(a)
- Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Atherosclerosis” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.